ARTICLE | Company News
QR Pharma, Michael J. Fox Foundation For Parkinson's Research neurology news
March 12, 2012 7:00 AM UTC
QR Pharma received a $468,000 grant from the foundation to develop Posiphen to treat Parkinson's disease. QR Pharma will conduct preclinical studies of the amyloid precursor protein (APP) translation ...